Reproduction number of SARS-CoV-2 Omicron variants, China, December 2022–January 2023

Author:

Bai Yuan123,Shao Zengyang3,Zhang Xiao3,Chen Ruohan3,Wang Lin4,Ali Sheikh Taslim125,Chen Tianmu6,Lau Eric H Y12,Jin Dong-Yan7,Du Zhanwei123

Affiliation:

1. WHO Collaborating Centre for Infectious Disease Epidemiology and Control , Li Ka Shing Faculty of Medicine, , Hong Kong Special Admimistrative Region , China

2. School of Public Health, The University of Hong Kong , Li Ka Shing Faculty of Medicine, , Hong Kong Special Admimistrative Region , China

3. Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region , China

4. Department of Genetics, University of Cambridge , Cambridge, CB2 3EH , UK

5. Laboratory of Data Discovery for Health, Hong Kong Science and Technology Park , Hong Kong Special Administrative Region , China

6. State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, School of Public Health, Xiamen University , Xiamen , China

7. Li Ka Shing Faculty of Medicine, School of Biomedical Sciences, The University of Hong Kong , Hong Kong Special Admimistrative Region , China

Abstract

China adjusted the zero-COVID strategy in late 2022, triggering an unprecedented Omicron wave. We estimated the time-varying reproduction numbers of 32 provincial-level administrative divisions from December 2022 to January 2023. We found that the pooled estimate of initial reproduction numbers is 4.74 (95% confidence interval: 4.41, 5.07).

Funder

National Natural Science Foundation of China

General Research Fund

Research Grant Council

Health and Medical Research Fund

HMRF Research Fellowship Scheme

Food and Health Bureau

Government of the Hong Kong Special Administrative Region

Hong Kong Special Administrative Region

Publisher

Oxford University Press (OUP)

Subject

General Medicine

Reference9 articles.

1. China focus: China releases measures to optimize COVID-19 response

2. China focus: COVID-19 response further optimized with 10 new measures

3. The impact of ending ‘zero COVID’ in China;Cowling;Nat Med,2023

4. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China;Tian;Science,2020

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3